NEW VISCOSUPPLEMENTS
4th Edition of the LABRHA European Board on Viscosupplementation / 07-08 September 2017

4th Edition of the LABRHA European Board on Viscosupplementation / 07-08 September 2017

2017 was no exception and after 3 successful editions, LABRHA organised last 07th and 08th of September 2017  its 4th LABRHA European Board on Viscosupplementation. 8 members of the EUROVISCO group participated this year. The group welcomed for this edition a new participant from Turkey, Prof. Demirhan Diracoglu, Physical Medicine and Rehabilitation specialist at the...
Safety and Efficacy of HAppyCross® in knee OA: Results of a Prospective Observational Study

Safety and Efficacy of HAppyCross® in knee OA: Results of a Prospective Observational Study

Safety and Efficacy of Single Intra-Articular Injection of a Cross-Linked Hyaluronic Acid/Mannitol Formulation [Happycross®] in knee Osteoarthritis Results of a Prospective Observational Study in Daily Practice Conditions. Monet M, Bozgan AM, Conrozier T. Ortho & Rheum Open Access 2017; 5(3): 555664. DOI: 10.19080/OROAJ.2017.05.555664. . This study has been conducted to assess in daily practice conditions,...
Retreatment with Viscosupplementation in Knee OA: Discover the 2nd paper of the EUROVISCO Group

Retreatment with Viscosupplementation in Knee OA: Discover the 2nd paper of the EUROVISCO Group

Decision Algorithms for the Retreatment with Viscosupplementation in Patients Suffering from Knee Osteoarthritis. Recommendations from the EUROpean VIScosupplementation COnsensus Group (EUROVISCO).R. Raman, Y. Henrotin, X. Chevalier, A. Migliore, J. Jerosch, J. Montfort, H. Bard, D. Baron, P. Richette, T. Conrozier. Cartilage. February-01-2017. Doi: 10.1177/1947603517693043 The paper « Decision Algorithms for the Retreatment with Viscosupplementation in Patients Suffering...
Obesity, radiological severity and lack of response of viscosupplementation in knee OA

Obesity, radiological severity and lack of response of viscosupplementation in knee OA

Viscosupplementation (VS) is still controversial. One of the key points is the lack of well-identified factors of response. The study « Obesity and radiological severity are associated with viscosupplementation failure in patients with knee osteoarthritis », published in Journal of Orthopaedic Research this month, has been designed to identify clinical and radiological factors associated with lack of...
Response to viscosupplementation with HAppyCross in hip OA: Discover the results in our published article

Response to viscosupplementation with HAppyCross in hip OA: Discover the results in our published article

Predictors of response to viscosupplementation in patients with hip osteoarthritis: results of a prospective, observational, multicentre, open-label, pilot study. Eymard et al. BMC Musculoskeletal Disorders (2017) 18:3. DOI 10.1186/s12891-016-1359-2. STUDY DESIGN Prospective, observational, multicentre, open-label study: 100 hip OA 59 men /41 women; mean age 62  (36-87) BMI 25,4 (17,9-41,8) 1 injection of HANOX-M-XL(HAppyCross®) under...